Top 10 Biotech Stocks with Highest Return on Equity: GTXI, OSIR, TLCR, GILD, CHBT, SCLN, PSDV, WX, SKBI, TECH (Nov 30, 2010)

Below are the top 10 Biotechnology stocks with highest Return on Equity (ROE) ratio for the last 12 months, UPDATED TODAY before 4:30 AM ET. ROE shows a company's efficiency in making profits from shareholders' equity. It is equal to net profits divided by shareholders' equity. Three Chinese companies (CHBT, WX, SKBI) are on the list. GTx, Inc. (NASDAQ:GTXI) has the 1st highest Return on Equity in this segment of the market. Its ROE was 132.69% for the last 12 months. Its net profit margin was 19.12% for the same period. Osiris Therapeutics, Inc. (NASDAQ:OSIR) has the 2nd highest Return on Equity in this segment of the market. Its ROE was 87.23% for the last 12 months. Its net profit margin was 19.56% for the same period. Talecris Biotherapeutics Holdings Corp (NASDAQ:TLCR) has the 3rd highest Return on Equity in this segment of the market. Its ROE was 76.35% for the last 12 months. Its net profit margin was 19.00% for the same period. Gilead Sciences, Inc. (NASDAQ:GILD) has the 4th highest Return on Equity in this segment of the market. Its ROE was 54.15% for the last 12 months. Its net profit margin was 38.37% for the same period. China-Biotics Inc. (NASDAQ:CHBT) has the 5th highest Return on Equity in this segment of the market. Its ROE was 34.03% for the last 12 months. Its net profit margin was 44.24% for the same period. SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) has the 6th highest Return on Equity in this segment of the market. Its ROE was 29.97% for the last 12 months. Its net profit margin was 24.80% for the same period. pSivida Corp. (NASDAQ:PSDV) has the 7th highest Return on Equity in this segment of the market. Its ROE was 27.47% for the last 12 months. Its net profit margin was 35.92% for the same period. WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) has the 8th highest Return on Equity in this segment of the market. Its ROE was 27.22% for the last 12 months. Its net profit margin was 26.94% for the same period. Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) has the 9th highest Return on Equity in this segment of the market. Its ROE was 26.77% for the last 12 months. Its net profit margin was 30.88% for the same period. Techne Corporation (NASDAQ:TECH) has the 10th highest Return on Equity in this segment of the market. Its ROE was 21.99% for the last 12 months. Its net profit margin was 40.44% for the same period.
tdp2664
Epic Stock Picks